**Question:** Type I Rapidly progressive glomerulonephritis is seen in

A. Membranous nephropathy
B. Goodpasture's syndrome
C. IgA nephropathy
D. Minimal change disease

**Correct Answer:** B. Goodpasture's syndrome

**Core Concept:** Type I Rapidly progressive glomerulonephritis refers to a group of clinical syndromes characterized by severe kidney damage and rapid decline in kidney function. These conditions typically manifest as a combination of hematuria, proteinuria, and hypertension. Goodpasture's syndrome is a subtype of Type I RPGN, characterized by an autoimmune response leading to the formation of anti-glomerular basement membrane (GBM) antibodies.

**Why the Correct Answer is Right:** Goodpasture's syndrome is caused by the production of antibodies against the glomerular basement membrane (GBM), leading to the destruction of the GBM and glomerular damage. This results in the clinical presentation of hematuria, proteinuria, and hypertension. The rapid progression of the disease explains why it is classified as Type I Rapidly progressive glomerulonephritis.

**Why Each Wrong Option is Incorrect:**

A. Membranous nephropathy is another form of glomerulonephritis, but it is caused by the deposition of immune complexes on the subepithelial region of the glomerular capillary wall, not the GBM. Membranous nephropathy is typically characterized by lower proteinuria and slower progression compared to Goodpasture's syndrome.

C. IgA nephropathy results from the deposition of IgA immune complexes in the mesangium, causing mesangial inflammation and subsequent glomerular damage. It typically presents with microscopic hematuria, proteinuria, and hypertension. The progression is usually slower compared to Goodpasture's syndrome.

D. Minimal change disease is characterized by the absence of histopathological findings, such as immune complex deposition, inflammation, or sclerosis. It is associated with a slower progression and milder clinical presentation compared to Goodpasture's syndrome.

**Clinical Pearl:** Goodpasture's syndrome is a severe autoimmune disorder with rapid progression, leading to end-stage kidney disease if left untreated. Prompt recognition and initiation of immunosuppressive therapy are crucial to improve the patient's prognosis.